SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging following a strong quarterly earnings report, driven by accelerating AI data center demand and optimistic forward-looking guidance. Investors are actively discussing the stock's parabolic trajectory and aggressive price target upgrades, with many comparing its current momentum to other chip sector leaders while debating whether the rapid valuation expansion is sustainable.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is experiencing intense parabolic growth and high volatility, fueled by structural memory supply shortages and aggressive demand for AI-focused data center hardware. The community is actively debating whether this movement represents a sustainable long-term re-rating driven by fundamental scarcity or an unsustainable speculative bubble reminiscent of past market excesses.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as community members spar over whether the stock is ripe for a short squeeze ahead of upcoming federal cannabis rescheduling catalysts or if it is a long-term underperformer plagued by dilution and poor leadership. Despite the divisive sentiment, discourse is heavily focused on whether current levels represent a massive buying opportunity or a signal to avoid the ticker entirely.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors rally behind the stock's global expansion strategy and the potential for a short squeeze amid heavy short interest. The community is actively discussing clinical data updates for Anktiva, upcoming earnings reports, and the intensifying scrutiny surrounding the FDA's regulatory environment.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as a major beneficiary of the AI memory supercycle, with community discussion highlighting an insatiable, multi-year supply-demand imbalance for HBM and enterprise SSDs. Investors are actively debating the sustainability of the stock's parabolic momentum, while many bullish participants argue that the company's strong forward earnings potential and critical role in AI infrastructure justify further upside.

Ethereum Classic

Ethereum Classic is experiencing significant community chatter as investors debate its long-term potential compared to other altcoins during a period of prolonged market volatility. Enthusiasts remain focused on its Proof of Work origins and upcoming technical upgrades, while others express frustration over stagnant price action and its distance from previous highs.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging after delivering strong earnings and updated guidance that reassured investors about the company's margin recovery and sustained demand for AI infrastructure. The community is actively debating the stock's potential for a massive short squeeze and long-term re-rating, highlighting that the company's current valuation remains significantly undervalued compared to its peers.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is surging following a multi-year colocation deal with AI compute firm Cerebras Systems, fueling intense community debate over its long-term potential versus concerns regarding dilution and volatility. Traders are actively monitoring the stock for momentum-driven gains, with significant discussion focused on whether the infrastructure contract will trigger a major re-rating as the Cerebras IPO approaches.

Wormhole is a cross-chain messaging protocol that enables secure transfers of data or tokens across different blockchain networks. It supports a variety of applications, including DeFi, NFTs, and governance, by allowing data to be moved between blockchains efficiently and securely. Wormhole employs multiple verification methods to ensure the integrity and validity of the data transmitted through its network.

Wormhole

Wormhole is seeing increased engagement as the community reacts to its role in cross-chain interoperability, particularly its integration with institutional partners and major networks like Ripple. Investors are actively debating the tokens potential for a breakout, driven by discussions around strategic reserves, tokenomics updates, and its utility as a bridge across blockchain ecosystems.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is surging following positive Phase 2 trial results for its drug candidate abdakibart, which successfully met primary endpoints for treating hidradenitis suppurativa. While the community is actively debating the potential for a short squeeze and the impact of a concurrently announced public offering, sentiment remains split between excitement over clinical progress and concerns regarding dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>PINS Q1 revenue and earnings beat estimates.&nbsp;</li><li>Expects second-quarter revenue in the range of $1.13 billion to $1.15 billion.</li><li>18 analysts rate the stock ‘buy’, 19 say ‘hold’ and one ‘sell’ as per Koyfin.</li></ul>Pinterest (PINS) stock surged 17% after-hours after beating Q1 revenue and earnings expectations, while a strong jump in its user base and robust guidance for the current quarter also aided sentiment.&nbsp;The online image-sharing platform’s adjusted earnings per share of $0.27 beat the analyst estimate of $0.23. Revenue reached $1.01 billion, surpassing the consensus estimate of $965.44 million, up 18% from $855 million in the same quarter last year.&nbsp;Pinterest has struggled to match the growing pace of Meta’s Facebook and Instagram; however, its recent AI investments in its Performance+ ad suite have helped raise its user base.&nbsp;The company’s global monthly active users gained 11% year-on-year (YoY) to hit an all-time high of 631 million, the tenth consecutive quarter of double-digit user expansion.&nbsp;“As we continue building an AI-powered ads platform that delivers performance for advertisers, we remain focused on ensuring monetization more fully reflects the strength of our engagement,” said Bill Ready, CEO of Pinterest.&nbsp;Pinterest has also garnered support from the recent $1 billion strategic investment made by activist investor Elliot in April, which backed the firm’s AI spending and monetization plans.&nbsp;Pinterest’s rivals, like Reddit, have also been increasing their AI spending to garner more advertiser interest.&nbsp;<h2 class="st-heading-2">PINS Q2 Guidance&nbsp;</h2>For Q2 2026, the company expects revenue to be in the range of $1.13 billion to $1.15 billion, representing 14% - 16% YoY growth, beating expectations of&nbsp; $1.12 billion.&nbsp;<h2 class="st-heading-2">PINS Retail View&nbsp;</h2>Retail sentiment on Stocktwits was ‘extremely bullish’ and message volumes were ‘extremely high’One user highlighted the stock’s low valuation and the potential for further gains if cash flows are maintained.&nbsp;<stembedurl>https://stocktwits.com/StockPlaza/message/652234699</stembedurl>The stock has lost 19.5% year-to-date.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Pinterest logo is seen displayed on a smartphone screen.

PINS Stock Jumps On Robust Advertiser Spending, Strong Q2 Guidance

PINS reports an all-time high of 631 million global monthly active users, an increase of 11% in Q1.

Equity

<ul class="summary-bullets"><li>The company anticipates incurring total pre-tax restructuring charges of approximately $35 million to $45 million.</li><li>Pinterest said it is taking these actions to support its transformation initiatives, reallocating resources to its AI push.&nbsp;</li><li>BofA in a note to investors said that the Pinterest announcement suggests tariff-related pressure on ad spend has likely continued into Q1.</li></ul>Shares of Pinterest plunged on Tuesday after it announced a board-approved global restructuring plan.&nbsp;The company’s restructuring plan includes a reduction in workforce that is expected to affect less than 15% of the company’s overall headcount as well as office space reductions.<h2 class="st-heading-2">Charges It Expects To Incur</h2>The company anticipates incurring total pre-tax restructuring charges of approximately $35 million to $45 million, which are expected to be primarily cash-related expenditures. The company intends to exclude the restructuring charges from its non-GAAP financial measures, including adjusted core profit.Pinterest had 5,205 full-time employees as of September last year. The job cut would translate to less than 780 positions.<h2 class="st-heading-2">AI Push</h2>The company said it is taking these actions to support its transformation initiatives, reallocating resources to AI-focused roles and teams that drive AI adoption and execution, prioritizing AI-powered products and capabilities, and accelerating the transformation of its sales and go-to-market approach.The company also added that although it is reducing its overall staffing levels with these actions in the near term, Pinterest plans to reinvest in key development areas and strategic opportunities.&nbsp;The company expects to complete the restructuring plan by the end of its third quarter ending September 30, 2026, subject to local law and consultation requirements, according to a regulatory filing.&nbsp;<h2 class="st-heading-2">Analysts Take</h2>Evercore ISI analyst Mark Mahaney notes the stock is currently trading off about 8%, which it believes is indicative of concerns around Pinterest's ability to reaccelerate U.S.-Canada (UCAN) growth in 2026.&nbsp;Evercore in a note to investors said that the announced restructuring slightly decreases the odds of a UCAN reacceleration this year. That said, the firm believes Pinterest has very reasonable valuation support at these levels, as per TheFly. Evercore has an ‘Outperform’ rating on the stock with a price target of $40.BofA in a note to investors said that the Pinterest announcement suggests tariff-related pressure on ad spend has likely continued into Q1. However, the reduction could enable Pinterest to maintain a margin growth trajectory toward low-30s EBITDA margins, the firm noted.&nbsp;The firm maintained a ‘Buy’ rating and $39 price target on Pinterest shares.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around PINS trended in ‘bullish’ territory amid ‘extremely high’ message volume.&nbsp;One bearish user said that ‘company has no chance of surviving on it’s own,’ while adding that it is a takeover candidate.&nbsp;<stembedurl>https://stocktwits.com/TrueGuru/message/643038834</stembedurl>Another user predicted stock to continue to fall on Wednesday.<stembedurl>https://stocktwits.com/BearBoB/message/643041538</stembedurl>Shares in the company have fallen 27.5% over the past 12 months. &nbsp;

Pinterest Is Plunging Today – What’s Its Global Restructuring Plan As Retail Sees It As Takeover Candidate

The company’s restructuring plan includes a reduction in workforce that is expected to affect less than 15%.

United Therapeutics Corporation (UTHR) announced on Tuesday that its study evaluating the use of nebulized Tyvaso Inhalation Solution for the treatment of idiopathic pulmonary fibrosis (IPF) demonstrated improvement in lung function relative to placebo.The late-stage study enrolled 597 patients across multiple locations, and Tyvaso demonstrated superiority over placebo in terms of the change in absolute forced vital capacity by 95.6 mL from baseline to week 52 in patients with IPF. Absolute forced vital capacity (FVC) is a measurement used to gauge lung health, referring to the total volume of air in liters that a person can forcibly exhale after taking a deep, maximum inhalation.Idiopathic pulmonary fibrosis, or IPF, is a scarring disease of the lungs of an unknown cause. It is characterized by the progressive loss of the ability of the lungs to transfer oxygen into the blood, ultimately resulting in respiratory failure and death. United Therapeutics estimates there are over 100,000 IPF patients in the United States.<a href="https://stocktwits.com/symbol/UTHR">UTHR stock</a> traded nearly 36% higher at the time of writing. On Stocktwits, retail sentiment around the shares jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume soared from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:624/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_02_at_12_13_28_PM_png_dae41f310b.webp" alt="UTHR's Sentiment Meter and Message Volume as of 12:13 p.m. ET on Sept. 2, 2025 | Source: Stocktwits" width="624" height="63"><figcaption>UTHR's Sentiment Meter and Message Volume as of 12:13 p.m. ET on Sept. 2, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user opined that the positive data implies more funding for more studies.<stembedurl>https://stocktwits.com/DonnyDonowitz/message/627212165</stembedurl>Another user expects the stock to close at $450.<stembedurl>https://stocktwits.com/wallstreet63/message/627228569</stembedurl>United Therapeutics <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.unither.com/press-releases/2025/09-02-2025-120037033">intends</a> to use the data from both the study and an ongoing study of nebulized Tyvaso to support a supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) to add IPF to the labeled indications for nebulized Tyvaso. Data from the ongoing study is expected in the first half of 2026, and the company plans to meet with the FDA before the end of the year to discuss ways to expedite the review process once the data is in, the company said.Following the announcement, multiple analysts hiked their price target on UTHR.<ul style="list-style-type:square;"><li>BofA raised its price target to $463 from $314 and kept a ‘Neutral’ rating on the shares. The firm said that the results were “surprisingly positive” and added that it expects $2.5 billion risk-adjusted peak sales for the drug in IPF.&nbsp;</li><li>Jefferies analyst Roger Song raised the firm's price target to $564 from $432 while keeping a ‘Buy’ rating on the shares.</li></ul>UTHR stock is up by 17% this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/bollinger-innovations-stock-plunges-after-announcing-cost-cutting-measures/chv6vkKRdF3">Why Did Bollinger Innovations Stock Plunge 18% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the United Therapeutics Corporation logo is seen displayed on a smartphone. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

This Pharma Stock Soared 36% Today And Drew Price Target Hikes From Wall Street – More Details Inside

The company reported that Tyvaso demonstrated superiority over the placebo in terms of the change in absolute forced vital capacity, increasing by 95.6 mL from baseline to week 52 in patients with idiopathic pulmonary fibrosis in the trial. 

GraniteShares ETF Trust - Graniteshares Nasdaq Select Disruptors ETF

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

DRUP
GraniteShares Nasdaq Select Disruptors ETF

Feed

News

Sentiment

Fundamentals

Info

Latest DRUP News

DRUPGraniteShares Nasdaq Select Disruptors ETF